Next Generation Networks For Neuroscience
Funding Opportunity Number: 16-569 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 47.04147.04947.07447.075Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: NSFClosing Date: Oct 21, 2016Award Ceiling: Expected Number of Awards: 15Creation Date: May 27, 2016Funding Opportunity Description: Understanding the brain is one of the grand scientifi...
Source: Grants.gov - May 27, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
Integrative Research on Polysubstance Abuse and Addiction (R21/R33)
Funding Opportunity Number: PAR-16-291 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthCFDA Number: 93.27393.27993.399Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3)...
Source: Grants.gov - May 26, 2016 Category: Research Tags: Education Health Source Type: funding
Integrative Research on Polysubstance Abuse and Addiction (R21/R33)
Funding Opportunity PAR-16-291 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is supported by Collaborative Research on Addiction (CRAN) at the National Institutes of Health (NIH), a trans-NIH partnership composed of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Drug Abuse (NIDA), and the National Cancer Institute (NCI). The intent of this FOA is two-fold: (1) characterize how the neurobiological alterations, associated behaviors, and public health consequences arising from polysubstance use differ from, or are similar to, those obs...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 26, 2016 Category: Research Source Type: funding
NIH Support for Conferences and Scientific Meetings (Parent R13)
(Source: NINDS Funding Announcements: National Institute of Neurological Disorders and Stroke)
Source: NINDS Funding Announcements: National Institute of Neurological Disorders and Stroke - May 26, 2016 Category: Neurology Source Type: funding
BD2K Open Educational Resources for Skills Development in Biomedical Big Data Science (R25)
(Source: NINDS Funding Announcements: National Institute of Neurological Disorders and Stroke)
Source: NINDS Funding Announcements: National Institute of Neurological Disorders and Stroke - May 18, 2016 Category: Neurology Source Type: funding
DoD Gulf War Illness Epidemiology Research Award
Funding Opportunity Number: W81XWH-16-GWIRP-GWIERA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Oct 20, 2016Award Ceiling: $0Expected Number of Awards: 1Creation Date: May 13, 2016Funding Opportunity Description: The Gulf War Illness Epide...
Source: Grants.gov - May 13, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21)
Funding Opportunity Number: PAR-16-257 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthCFDA Number: 93.393Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) status with...
Source: Grants.gov - May 11, 2016 Category: Research Tags: Education Health Source Type: funding
Predicting Behavioral Responses to Population-Level Cancer Control Strategies (R21)
Funding Opportunity PAR-16-257 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity announcement (FOA) is to facilitate research to identify individual influences on the effectiveness of population-level strategies that target cancer-related behaviors. We seek to encourage collaborations among scientists with expertise in health policy research and implementation, as well as investigators in scientific disciplines that have not traditionally conducted cancer or policy research, such as: psychological science (e.g., social, developmental); affective and cognitive neuroscience; judgment and...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 11, 2016 Category: Research Source Type: funding
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01)
Funding Opportunity Number: PAR-16-234 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: EducationHealthCFDA Number: 93.27393.27993.399Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3)...
Source: Grants.gov - May 10, 2016 Category: Research Tags: Education Health Source Type: funding
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01)
Funding Opportunity PAR-16-234 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to incr...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 10, 2016 Category: Research Source Type: funding
DoD Neurofibromatosis Exploration-Hypothesis Development Award
Funding Opportunity Number: W81XWH-16-NFRP-EHDA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Aug 01, 2016Award Ceiling: Expected Number of Awards: 5Creation Date: May 09, 2016Funding Opportunity Description: The NFRP Exploration – Hypothe...
Source: Grants.gov - May 10, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
DoD Neurofibromatosis Clinical Trial Award
Funding Opportunity Number: W81XWH-16-NFRP-CTA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Aug 01, 2016Award Ceiling: Expected Number of Awards: 1Creation Date: May 09, 2016Funding Opportunity Description: The NFRP Clinical Trial Award sup...
Source: Grants.gov - May 10, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
DoD Neurofibromatosis New Investigator Award
Funding Opportunity Number: W81XWH-16-NFRP-NIA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Aug 01, 2016Award Ceiling: Expected Number of Awards: 4Creation Date: May 09, 2016Funding Opportunity Description: The intent of the NFRP New Invest...
Source: Grants.gov - May 10, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
DoD Neurofibromatosis Investigator-Initiated Research Award
Funding Opportunity Number: W81XWH-16-NFRP-IIRA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Aug 01, 2016Award Ceiling: Expected Number of Awards: 2Creation Date: May 09, 2016Funding Opportunity Description: The NFRP Investigator-Initiated ...
Source: Grants.gov - May 10, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
DoD Neurofibromatosis Clinical Consortium Award
The objectives of the Consortium shall be to conceive, design, develop, and conduct collaborative Phase I and II clinical evaluations of promising therapeutic agents for the management or treatment of NF1, NF2, and schwannomatosis. The NF Clinical Consortium needs to be a collaboration of multiple organizations and individuals for the purpose of rapidly executing clinical trials. The Consortium must consist of a single Operations Center and a minimum of five Clinical Trial Sites with a demonstrated history of collaborative research. The participants will be jointly responsible for prioritizing, proposing, conducting, an...
Source: Grants.gov - May 6, 2016 Category: Research Tags: Science and Technology and other Research and Development Source Type: funding
